Dec 26th, 2022
Late-Breaking Science for #ISC23
14 late-breaking presentations have been selected for the Main Events of #ISC23.
Times are subject to change. Please check the online program planner for the most up-to-date information.
Opening Main Event
11 a.m.-12:30 p.m., Wednesday, Feb. 8
- Primary Results of the Stroke Preclinical Assessment Network
- 3-Year Results From the STROKE-AF Randomized Trial
- April: A Double-Blind, Placebo-Controlled, Randomized, Phase Ib/IIa Clinical Study of Aptoll for the Treatment of Acute Ischemic Stroke
Thursday Main Event
11 a.m.-12:30 p.m., Thursday, Feb. 9
- Increased Acute Stroke Treatment Rates in Flint, Michigan: Results From Stroke Ready: A Community Engaged Emergency Department and Community Intervention
- Tenecteplase Versus Alteplase in Acute Ischemic Cerebrovascular Events (TRACE II): A Phase 3, Multicenter, Open-Label, Randomized Controlled, Non-Inferiority Trial
- Cilostazol, Isosorbide Mononitrate and Their Combination to Prevent Recurrence and Dependency In Patients With Small Vessel Disease Stroke: The Lacunar Intervention Trial-2 (LACI-2)
- Isosorbide Mononitrate, Cilostazol and Their Combination To Prevent Cognitive Impairment in Patients With Small Vessel Disease Stroke: The LACunar Intervention Trial-2 (LAC-2)
Closing Main Event
11 a.m.- 1:05 p.m., Friday, Feb. 10
- Blood Pressure After Endovascular Stroke Treatment (BEST)-II: A Randomized Clinical
- Early Antihypertensive Treatment With Delayed Antihypertensive Treatment for Acute Ischemic Stroke (CATIS-2): A Multicenter Randomized, Open-Label, Blinded-Endpoint, Phase 3 Trial
- A Randomized Trial of Endovascular Therapy for Acute Ischemic Stroke With a Large Infarct Core
- A Randomized Trial of Endovascular Thrombectomy Versus Medical Management for Ischemic Stroke With a Large Ischemic Core on Non-Contrast CT or Perfusion Imaging
- Antiplatelet Versus Alteplase in Acute Mild Ischaemic Stroke (ARAMIS): A Multicenter, Open-Label, Blinded-Endpoint, Randomized, Controlled, Noninferiority Trial
- Tirofiban For Disabling Stroke Without Large or Medium Vessel Occlusion
- Extracranial-Intracranial Bypass Surgery Versus Medical Therapy for Symptomatic Carotid and Middle Cerebral Artery Occlusion: Results of the CMOSS Multicenter Randomized Trial
